ArticleBMJ case reports2022

Immunotherapy in stage IV non-small cell lung cancer in a patient with Grave's disease: safety and biomarkers of response.

Marta Vilaça et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.